Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease

This publication has 22 references indexed in Scilit:

• Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction
  American Journal of Kidney Diseases, 2001
• Effect of Beta-Blockade on Mortality among High-Risk and Low-Risk Patients after Myocardial Infarction
  New England Journal of Medicine, 1998
• Acute Renal Failure After Coronary Intervention
  The American Journal of Medicine, 1997
• Serum Creatinine Concentration and Risk of Cardiovascular Disease
  Stroke, 1997
• Preoperative Renal Risk Stratification
  Circulation, 1997
• Predictability of creatinine clearance estimates in critically ill patients
  Critical Care Medicine, 1993
• Cardiovascular disease risk profiles
  American Heart Journal, 1991
• Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition.
  Journal of Clinical Investigation, 1987
• Bleeding time in Uremia: A useful test to assess clinical bleeding
  American Journal of Hematology, 1979
• Prediction of Creatinine Clearance from Serum Creatinine
  Nephron, 1976